Zymeworks: Adjusting My Levels After Ziihera's Phase III Data For GEA [Seeking Alpha]
Zymeworks Inc. (ZYME)
Last zymeworks inc. earnings: 3/2 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.zymeworks.com/overview
Company Research
Source: Seeking Alpha
ZYME's royalty-based business model with partners like Jazz and BeOne enables pipeline focus while targeting blockbuster potential, with peak sales estimates exceeding $2B for Ziihera. Risks remain, including regulatory uncertainties and competition from ENHERTU, but ZYME's solid cash position and clinical progress support a 3/5 conviction rating. Buy and sell levels have been recalibrated higher, with a new buy threshold at $10.45 and sell levels up to $37.68, reflecting increased confidence in ZYME's outlook. primeimages/iStock via Getty Images It has been nearly 5 years since my last Zymeworks ( ZYME article , and I'm finally starting to see my investment thesis begin to harden as Ziihera starts to stack strong clinical data on top of its accelerated More on my IG service Thank you for reading my research on Seeking Alpha. If you want to learn even more about my method and how I discover these investment opportunities, please check out my subscription marketplace servi
Show less
Read more
Impact Snapshot
Event Time:
ZYME
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZYME alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZYME alerts
High impacting Zymeworks Inc. news events
Weekly update
A roundup of the hottest topics
ZYME
News
- Zymeworks (NYSE:ZYME) is now covered by analysts at Citizens Jmp. They set an "outperform" rating and a $32.00 price target on the stock.MarketBeat
- Zymeworks (NYSE:ZYME) was given a new $32.00 price target on by analysts at JMP Securities.MarketBeat
- Zymeworks (NYSE:ZYME) is now covered by analysts at Citigroup Inc.. They set an "outperform" rating on the stock.MarketBeat
- Zymeworks Announces Participation in Upcoming ConferencesGlobeNewswire
- Zymeworks (NASDAQ:ZYME) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.MarketBeat
ZYME
Earnings
- 11/6/25 - Beat
ZYME
Sec Filings
- 11/24/25 - Form 144
- 11/21/25 - Form 144
- 11/19/25 - Form SCHEDULE
- ZYME's page on the SEC website